作者: Estelle Grasset , Anthony Puel , Julie Charpentier , Xavier Collet , Jeffrey E. Christensen
DOI: 10.1016/J.CMET.2017.06.003
关键词: Endocrinology 、 Internal medicine 、 Gut–brain axis 、 Dysbiosis 、 Gut flora 、 Receptor 、 Enteric nervous system 、 Gastric emptying 、 Biology 、 Nitric oxide 、 Diabetes mellitus
摘要: Summary Glucagon-like peptide-1 (GLP-1)-based therapies control glycemia in type 2 diabetic (T2D) patients. However, in some patients the treatment must be discontinued, defining a state of GLP-1 resistance. In animal models we identified a specific set of ileum bacteria impairing the GLP-1-activated gut-brain axis for the control of insulin secretion and gastric emptying. Using prediction algorithms, we identified bacterial pathways related to amino acid metabolism and transport system modules associated to GLP-1 resistance. The …